Insider · CIK 0001260835

German Christopher Paul

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001260835

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,687 sh	$56.69	+$95.6K	1,888
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,349 sh	$49.23	+$66.4K	3,237
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,406 sh	$17.97	+$25.3K	4,643
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−4,643 sh	$92.21	−$428K	0
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,687 sh	—	—	3,713
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,349 sh	—	—	2,701
2026-05-15	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,406 sh	—	—	2,325
2026-03-04	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,500 sh	$17.97	+$27K	5,753
2026-03-04	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−5,614 sh	$89.56	−$503K	160
2026-03-04	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,500 sh	—	—	3,731
2026-03-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,162 sh	—	—	4,595
2026-03-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	Corporate Controller & CAO	FTax Payment	−342 sh	$94.94	−$32.5K	4,253
2026-03-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,162 sh	—	—	1,162
2026-02-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Corporate Controller & CAO	AAward	+5,215 sh	—	—	5,215
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+3,613 sh	—	—	4,571
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC.F Tax Payment	Corporate Controller & CAO	FTax Payment	−1,138 sh	$108.99	−$124K	3,433
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,806 sh	—	—	3,612
2026-02-01	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,807 sh	—	—	5,418
2025-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,000 sh	$17.97	+$18K	1,922
2025-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+500 sh	$49.23	+$24.6K	1,422
2025-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−1,500 sh	$95.00	−$143K	922
2025-08-12	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,000 sh	—	—	5,231
2025-08-12	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−500 sh	—	—	4,050
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+2,000 sh	$17.97	+$35.9K	3,889
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+850 sh	$49.23	+$41.8K	4,739
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−1,967 sh	$76.75	−$151K	2,772
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−1,850 sh	$85.00	−$157K	922
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−2,000 sh	—	—	6,231
2025-07-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−850 sh	—	—	4,550
2025-06-10	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,069 sh	$17.97	+$19.2K	3,958
2025-06-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−2,069 sh	$67.19	−$139K	1,889
2025-06-10	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,069 sh	—	—	8,231
2025-03-21	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−344 sh	$54.23	−$18.7K	2,889
2025-03-20	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,163 sh	—	—	3,233
2025-03-20	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,163 sh	—	—	2,324
2025-02-19	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−635 sh	$57.22	−$36.3K	2,070
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,807 sh	—	—	2,705
2025-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,807 sh	—	—	5,418
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Corporate Controller & CAO	AAward	+7,225 sh	—	—	7,225
2025-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Options (Right to Buy)A Award	Corporate Controller & CAO	AAward	+5,400 sh	—	—	5,400
2024-04-02	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Corporate Controller & CAO	SSale	−368 sh	$41.76	−$15.4K	795
2024-03-20	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	+1,163 sh	—	—	1,163
2024-03-20	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Corporate Controller & CAO	MExercise/Conversion	−1,163 sh	—	—	3,487
2024-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Corporate Controller & CAO	AAward	+7,225 sh	—	—	7,225
2024-02-16	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Corporate Controller & CAO	AAward	+5,400 sh	—	—	5,400

Recent filings

Accepted (ET)
May 194
German Christopher Paul0001104659-26-063830
SEC(opens sec.gov)
Mar 64
German Christopher Paul0001104659-26-024750
SEC(opens sec.gov)
Mar 34
German Christopher Paul0001104659-26-023018
SEC(opens sec.gov)
Feb 134
German Christopher Paul0001104659-26-015398
SEC(opens sec.gov)
Feb 34
German Christopher Paul0001104659-26-009766
SEC(opens sec.gov)
Aug 144
German Christopher Paul0001104659-25-078814
SEC(opens sec.gov)

Companies

RHYTHM PHARMACEUTICALS, INC.Corporate Controller & CAORYTM

Address

222 BERKELEY STREET, 12TH FLOOR

BOSTON, MA, 02116